Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000433255

Medchemexpress LLC Ac-Exatecan | 2922852-48-8 | 99.0% | C26H24FN3O5 | 50 MG
SDP

Catalog No. 5000433255
Encompass_Preferred

Ac-Exatecan is an acetylation-modified Exatecan, which acts as a common toxin component in Antibody-Drug Conjugate (ADC) preparation and is an inhibitor of DNA topoisomerase I (IC50 = 2.2 μM). This compound demonstrates antitumor activity and can serve as a payload for ADCs. Furthermore, Exatecan is effective against P-glycoprotein-mediated multi-drug resistant cells. This product is for research use only.

  • Acetylation-modified Exatecan
  • Common toxin component in antibody-drug conjugate (ADC) preparation
  • Inhibitor of DNA topoisomerase I (IC50 = 2.2 μM)
  • Demonstrates antitumor activity
  • Can serve as a payload for ADCs
  • Effective against P-glycoprotein-mediated multi-drug resistant cells

Catalog No. 50-004-33255 Supplier Medchemexpress LLC Supplier No. HY7949050MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Ac-Exatecan is an acetylation-modified Exatecan, which acts as a common toxin component in Antibody-Drug Conjugate (ADC) preparation and is an inhibitor of DNA topoisomerase I (IC50 = 2.2 μM). This compound demonstrates antitumor activity and can serve as a payload for ADCs. Furthermore, Exatecan is effective against P-glycoprotein-mediated multi-drug resistant cells. This product is for research use only.

  • Acetylation-modified Exatecan
  • Common toxin component in antibody-drug conjugate (ADC) preparation
  • Inhibitor of DNA topoisomerase I (IC50 = 2.2 μM)
  • Demonstrates antitumor activity
  • Can serve as a payload for ADCs
  • Effective against P-glycoprotein-mediated multi-drug resistant cells

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.